Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 106

1.

Comparative analysis of nanosystems' effects on human endothelial and monocytic cell functions.

Matuszak J, Dörfler P, Lyer S, Unterweger H, Juenet M, Chauvierre C, Alaarg A, Franke D, Almer G, Texier I, Metselaar JM, Prassl R, Alexiou C, Mangge H, Letourneur D, Cicha I.

Nanotoxicology. 2018 Sep 28:1-18. doi: 10.1080/17435390.2018.1502375. [Epub ahead of print]

PMID:
30265172
2.

From Design to the Clinic: Practical Guidelines for Translating Cardiovascular Nanomedicine.

Cicha I, Chauvierre C, Texier I, Cabella C, Metselaar JM, Szebeni J, Alexiou C, Rouzet F, Storm G, Stroes E, Bruce D, MacRitchie N, Maffia P, Letourneur D.

Cardiovasc Res. 2018 Aug 27. doi: 10.1093/cvr/cvy219. [Epub ahead of print]

PMID:
30165574
3.

Investigation of phonatory characteristics using ex vivo rabbit larynges.

Döllinger M, Kniesburges S, Berry DA, Birk V, Wendler O, Dürr S, Alexiou C, Schützenberger A.

J Acoust Soc Am. 2018 Jul;144(1):142. doi: 10.1121/1.5043384.

PMID:
30075689
4.

ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria.

Reshetnikov V, Daum S, Janko C, Karawacka W, Tietze R, Alexiou C, Paryzhak S, Dumych T, Bilyy R, Tripal P, Schmid B, Palmisano R, Mokhir A.

Angew Chem Int Ed Engl. 2018 Sep 10;57(37):11943-11946. doi: 10.1002/anie.201805955. Epub 2018 Aug 20.

PMID:
30035345
5.

Targeting of drug-loaded nanoparticles to tumor sites increases cell death and release of danger signals.

Alev M, Egenberger L, Mühleisen L, Weigel B, Frey B, Friedrich RP, Pöttler M, Alexiou C, Janko C.

J Control Release. 2018 Sep 10;285:67-80. doi: 10.1016/j.jconrel.2018.07.007. Epub 2018 Jul 4. No abstract available.

PMID:
30008372
6.

'Nano-lysing' the disease process: novel diagnostic and therapeutic nanoparticles.

Janko C, Friedrich RP, Pöttler M, Cicha I, Lyer S, Unterweger H, Alexiou C.

Nanomedicine (Lond). 2018 May;13(10):1087-1091. doi: 10.2217/nnm-2018-0061. Epub 2018 Jun 6. No abstract available.

PMID:
29874148
7.

Surface Modification of SPIONs in PHBV Microspheres for Biomedical Applications.

Idris MI, Zaloga J, Detsch R, Roether JA, Unterweger H, Alexiou C, Boccaccini AR.

Sci Rep. 2018 May 8;8(1):7286. doi: 10.1038/s41598-018-25243-9.

8.

Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety.

Unterweger H, Dézsi L, Matuszak J, Janko C, Poettler M, Jordan J, Bäuerle T, Szebeni J, Fey T, Boccaccini AR, Alexiou C, Cicha I.

Int J Nanomedicine. 2018 Mar 28;13:1899-1915. doi: 10.2147/IJN.S156528. eCollection 2018.

9.

Biomechanical simulation of vocal fold dynamics in adults based on laryngeal high-speed videoendoscopy.

Döllinger M, Gómez P, Patel RR, Alexiou C, Bohr C, Schützenberger A.

PLoS One. 2017 Nov 9;12(11):e0187486. doi: 10.1371/journal.pone.0187486. eCollection 2017.

10.

Treat or track: nanoagents in the service of health.

Lyer S, Janko C, Friedrich RP, Pöttler M, Cicha I, Alexiou C.

Nanomedicine (Lond). 2017 Dec;12(24):2715-2719. doi: 10.2217/nnm-2017-0293. Epub 2017 Nov 3. No abstract available.

11.

The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer.

Stiasny A, Freier CP, Kuhn C, Schulze S, Mayr D, Alexiou C, Janko C, Wiest I, Dannecker C, Jeschke U, Kost BP.

Oncol Lett. 2017 Oct;14(4):4467-4476. doi: 10.3892/ol.2017.6752. Epub 2017 Aug 14.

12.

Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.

Zaloga J, Feoktystov A, Garamus VM, Karawacka W, Ioffe A, Brückel T, Tietze R, Alexiou C, Lyer S.

Colloids Surf B Biointerfaces. 2018 Jan 1;161:18-26. doi: 10.1016/j.colsurfb.2017.09.057. Epub 2017 Sep 28.

PMID:
29035747
13.

Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution.

Daum S, Babiy S, Konovalova H, Hofer W, Shtemenko A, Shtemenko N, Janko C, Alexiou C, Mokhir A.

J Inorg Biochem. 2018 Jan;178:9-17. doi: 10.1016/j.jinorgbio.2017.08.038. Epub 2017 Sep 15.

PMID:
29028541
14.

Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs.

Daum S, Reshetnikov MSV, Sisa M, Dumych T, Lootsik MD, Bilyy R, Bila E, Janko C, Alexiou C, Herrmann M, Sellner L, Mokhir A.

Angew Chem Int Ed Engl. 2017 Dec 4;56(49):15545-15549. doi: 10.1002/anie.201706585. Epub 2017 Nov 9.

PMID:
28994179
15.

Pedicled Transplantation of Axially Vascularized Bone Constructs in a Critical Size Femoral Defect.

Arkudas A, Lipp A, Buehrer G, Arnold I, Dafinova D, Brandl A, Beier JP, Körner C, Lyer S, Alexiou C, Kneser U, Horch RE.

Tissue Eng Part A. 2018 Mar;24(5-6):479-492. doi: 10.1089/ten.TEA.2017.0110. Epub 2017 Oct 25.

PMID:
28851253
16.

Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution.

Heid S, Unterweger H, Tietze R, Friedrich RP, Weigel B, Cicha I, Eberbeck D, Boccaccini AR, Alexiou C, Lyer S.

Int J Mol Sci. 2017 Aug 24;18(9). pii: E1837. doi: 10.3390/ijms18091837.

17.

Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment.

Heidkamp GF, Sander J, Lehmann CHK, Heger L, Eissing N, Baranska A, Lühr JJ, Hoffmann A, Reimer KC, Lux A, Söder S, Hartmann A, Zenk J, Ulas T, McGovern N, Alexiou C, Spriewald B, Mackensen A, Schuler G, Schauf B, Forster A, Repp R, Fasching PA, Purbojo A, Cesnjevar R, Ullrich E, Ginhoux F, Schlitzer A, Nimmerjahn F, Schultze JL, Dudziak D.

Sci Immunol. 2016 Dec 16;1(6). pii: eaai7677. doi: 10.1126/sciimmunol.aai7677. Epub 2016 Dec 16.

PMID:
28783692
18.

Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.

Unterweger H, Janko C, Schwarz M, Dézsi L, Urbanics R, Matuszak J, Őrfi E, Fülöp T, Bäuerle T, Szebeni J, Journé C, Boccaccini AR, Alexiou C, Lyer S, Cicha I.

Int J Nanomedicine. 2017 Jul 24;12:5223-5238. doi: 10.2147/IJN.S138108. eCollection 2017.

19.

Analysis of Hypericin-Mediated Effects and Implications for Targeted Photodynamic Therapy.

Mühleisen L, Alev M, Unterweger H, Subatzus D, Pöttler M, Friedrich RP, Alexiou C, Janko C.

Int J Mol Sci. 2017 Jun 29;18(7). pii: E1388. doi: 10.3390/ijms18071388.

20.

Cell specificity of magnetic cell seeding approach to hydrogel colonization.

Singh R, Wieser A, Reakasame S, Detsch R, Dietel B, Alexiou C, Boccaccini AR, Cicha I.

J Biomed Mater Res A. 2017 Nov;105(11):2948-2957. doi: 10.1002/jbm.a.36147. Epub 2017 Jul 14.

PMID:
28639348

Supplemental Content

Loading ...
Support Center